Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria-Paula Avila"'
Autor:
Jose Sanabria, Vivian Garzón, Tatiana Pacheco, Maria-Paula Avila, Julio-Cesar Garcia, Diego Jaimes, Angela Torres, Rosa-Helena Bustos, Javier Escobar-Perez, Deisy Abril
Publikováno v:
Pharmaceutics, Vol 13, Iss 10, p 1630 (2021)
In recent decades, antimicrobial resistance (AMR) has led to an increased use of therapeutic alternatives. Among these options, colistin continues to be an option for the treatment of multi-resistant (MDR) Gram-negative bacterial infections. However,
Externí odkaz:
https://doaj.org/article/96a4f51c267247f6a1949ff6a4bb055d
Autor:
Maria-Paula Avila, Tatiana Pacheco, Sara Arias, Rosa-Helena Bustos, Julio-Cesar Garcia, Diego Jaimes
Publikováno v:
Pharmaceuticals, Vol 13, Iss 3, p 42 (2020)
Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence o
Externí odkaz:
https://doaj.org/article/da4ce9a20c6e49b6964cbd0b8be698f4
Autor:
Diego Jaimes, Julio César García, Maria Paula Avila, Rosa-Helena Bustos, Tatiana Pacheco, Sara Arias
Publikováno v:
Pharmaceuticals, Vol 13, Iss 3, p 42 (2020)
Pharmaceuticals
Pharmaceuticals
Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac14f5ee0a41120f5d3f9abe065c2c97
https://doi.org/10.3390/ph13030042
https://doi.org/10.3390/ph13030042